HER2 Expression Associated with Clinical Characteristics and Prognosis of Urothelial Carcinoma in a Chinese Population.
Li ZhouZhiting ShaoYiqiang LiuXieqiao YanJuan LiXiaowen WuBixia TangSiming LiChuanliang CuiZhihong ChiLu SiYan KongLili MaoBin LianXuan WangXue BaiJie DaiJun GuoXinan ShengPublished in: The oncologist (2023)
DV has improved the survival of patients with urothelial carcinoma in the real world. With the new-generation anti-HER2 ADC treatment, HER2 expression is no longer a poor prognostic factor.